期刊文献+

肿瘤与microRNA的DNA甲基化相关性研究进展 被引量:3

Research progress of DNA methylation of microRNA in tumors
原文传递
导出
摘要 目的:总结国内外关于microRNA(miRNA)的DNA甲基化在各肿瘤中的研究进展。方法:应用PubMed及CNKI全文数据库检索系统,以"miRNA、DNA甲基化和肿瘤"为检索词,检索2004-04-2012-05的相关文献,共检索到英文文献401篇,中文文献40篇。文献纳入标准:1)miRNA的生物学特性;2)DNA甲基化的作用机制及与肿瘤的关系;3)miRNA的DNA甲基化与肿瘤发生发展的关系。根据纳入标准符合分析的文献27篇。结果:miRNA在肿瘤发生发展中可发挥癌基因和抑癌基因的作用,DNA甲基化是肿瘤发生的一个重要因素。20%受甲基化调控的miRNA在上游5kb范围内有CpG岛,miRNA的DNA甲基化与CpG岛有密切关系。miR-34、miR-124、miR-9和miR-127的DNA甲基化在各种肿瘤中频繁发生,多数通过靶向调节癌基因或抑癌基因而在肿瘤发生发展中发挥作用。结论:miRNA的DNA甲基化在人类肿瘤中广泛存在,甲基化miRNA可能作为肿瘤早期诊断、治疗、转移和预后的分子标志。 OBJECTIVE:To review the recent progresses about microRNA(miRNA) regulated by DNA methylation in tumorsat home and abroad. METHODS: The literatures with “miRNA, regulated by DNA methylation and tumors” as key words were retrieved in PubMed and CNKI from 2004-04 to 2012 05. Total 401 English papers and 40 Chinese papers were obtained. The selection criteria: 1) the bionomics of miRNA; 2) the mechanism of DNA methylation and its relation- ship with tumors; 3) DNA methylation of miRNA in kinds of tumors. According to the critenia,27 papers were involved. RESULTS:miRNA can act as oncogene or antioncogene through DNA methylation in tumors. Totally 20% of miRNA reg- ulated by DNA metylation is with CpG Island inside in 5kb region,so DNA methylation of miRNA is closely related with CpG Island. miR-34 ,miR-124,miR-9 and miR-127 are frequently methylated in kinds of tumors,most of which play roles in tumor progression by targeting oncogenes or antioncogenes. CONCLUSION: miRNA regulated by DNA methylation widely exists in human tumors, and can be used in tumor early diagnosis, treatment, metastasis and prognosis.
出处 《中华肿瘤防治杂志》 CAS 北大核心 2012年第24期1919-1922,共4页 Chinese Journal of Cancer Prevention and Treatment
基金 北京市教委科技计划面上项目(KM2010100-25022)
关键词 MICRORNA DNA甲基化 肿瘤 综述文献 microRNA DNA methylation tumors review literature
  • 相关文献

参考文献27

  • 1Li XQ,Guo YY,De W. DNA methylation and microRNAs in cancer[J].World Journal of Gastroenterology,2012,(09):882-888.
  • 2裴雷,夏加增.微小RNA的DNA甲基化与肿瘤发生发展相关性的研究进展[J].中华肿瘤防治杂志,2010,17(19):1591-1594. 被引量:5
  • 3Ferdin J,Kunej T,Calin GA. Non-coding RNAs:identification of cancer-associated microRNAs by gene profiling[J].Technol CancerResTreat,2010,(02):123-138.
  • 4Iorio MV,Piovan C,Croce CM. Interplay between microRNAs and the epigenetic machinery:an intricate network[J].Biochimica Et Biophysica Acta,2010,(10-12):694-701.
  • 5Mandke P,Wyatt N,Fraser J. MicroRNA-34a Modulates MDM4 Expression via a Target Site in the Open Reading Frame[J].PLoS One,2012,(08):e42034.
  • 6钟琦,房居高,黄志刚,陈晓红,周维国,陈学军,许洪波,马泓智.喉鳞状细胞癌组织miRNA表达的初步研究[J].中华肿瘤防治杂志,2010,17(14):1073-1076. 被引量:28
  • 7Saito Y,Liang G,Egger G. Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells[J].Cancer Cell,2006,(06):435-443.doi:10.1016/j.ccr.2006.04.020.
  • 8Kunej T,Godnic I,Ferdin J. Epigenetic regulation of microRNAs in cancer:an integrated review of literature[J].Mutation Research,2011,(1-2):77-84.
  • 9Lodygin D,Tarasov V,Epanchintsev A. Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer[J].Cell Cycle,2008,(16):2591-2600.doi:10.4161/cc.7.16.6533.
  • 10Toyota M,Suzuki H,Sasaki Y. Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer[J].Cancer Research,2008,(11):4123-4132.

二级参考文献27

  • 1Parkin D M, Bray F, Ferlay J, et al. Global cancer statistics, 2002[J]. CA Cancer J Clin, 2005,55(2):74-108.
  • 2Jaseviciene L, Gurevicius R, Obelenis V, et al. Trends in laryngeal cancer incidence in Lithuania: a future perspective[J]. Int J Occup Med Environ Health, 2004,17(4) : 473-477.
  • 3Liu X, Chen Z, Yu J, et al. MicroRNA profiling and head and neck cancer[J]. Comp Funct Genomics, 2009,1:1- 11.
  • 4Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008[J]. CA Cancer J Clin, 2008,58(2) :71-96.
  • 5International Human Genome Sequencing Consortium. Finishing the euehromatic sequence of the human genome[J]. Nature, 2004,431 :931 -945.
  • 6Bentwich I, Avniel A, Karov Y, et al. Identification of hundreds of conserved and nonconserved human microRNAs[J]. Nat Genet, 2005,37(7) :766 -770.
  • 7Filipowicz W, Bhattacharyya S N, Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? [J]. Nat Rev Genet, 2008,9(2):102-114.
  • 8Takamizawa J, Konishi H, Yanagisawa K, et al. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival[J]. Cancer Res, 2004,64(11) :3753- 3756.
  • 9Kondo N, Toyama T, Sugiura H, et al. miR-206 Expression is down regulated in estrogen receptor alpha-positive human breast cancer[J]. Cancer Res, 2008,68(13) :5004-5008.
  • 10Wong Q W, Lung R W, Law P T, et al. MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathminl [J]. Gastroenterology, 2008,135(1): 257-269.

共引文献30

同被引文献41

  • 1马文慧,侯琳,韩琳琳.BRCA1基因甲基化及甲硫氨酸合成酶与乳腺癌发病的关系[J].中国癌症杂志,2011,21(4):256-261. 被引量:6
  • 2Cao W,Wang X,Li JC. Hereditary breast cancer in the HAN chi-nese population[J]. Am J Epidemiol,2013,23(2) :75-84.
  • 3Ou JH,Wu T’Sijmons R, et al. Prevalence of BRCAl and BRCA2germline mutations in breast cancer women of multiple ethnic region innorthwest china[J]. J Breast Cancer,2013,16(1) :50*54.
  • 4Kwon JS,Barrera 八M, Young D,et al. Expanding the criteria forHRCA mutation testing in breast cancer survivors[J]. Am J ClinC)ncol,2010,28(27) :4214-4220.
  • 5Wang F,Fang Q,Ge Z’et al. Common BRCAl and BRCA2 mu-tations in breast cancer families:a meta-analysis from systematicreview[J]. Mol Biol Rep,2012 ,39(3) : 2109-2118.
  • 6Delpu Y,Cordelier P,Cho WC,et al. DNA methylation and cancerdiagnosis[J]. Int J Mol Sci,2013,14(7) : 15029-15058.
  • 7Wei J. Han B, Mao XY,et al. Promoter methylation status andexpression of estrogen receptor alpha in familial breast cancer pa-tients[J]. Tumour Biol,2012,33(2) :413-420.
  • 8Iwamoto T, Yamamoto N. Taguchi T,et al. BRCAl promotermethylation in peripheral blood cells is associated with increasedrisk of breast cancer with BRCAl promoter methylation [ J].Breast Cancer Res Treat,2011,129(1) . 69-77.
  • 9Bosviel R,Durif J,Guo J,et al. BRCA2 promoter hypermethyla-tion in sporadic breast cancer[J]. OMICS,2012, 16 ( 12) : 707-710.
  • 10Bal A, Verma S, Joshi K, et al. BRCAl-methylated sporadic breastcancers are BRCA-like in showing a basal phenotype and absence ofER expression[J]. Virchows Arch,2012,461(3) :305-312.

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部